ceritinib

Spain

Drugs containing this active substance

  • ZYKADIA 150 MG HARD CAPSULES

    It is used to treat adult patients with advanced stages of a type of lung cancer called non-small cell lung cancer (NSCLC), provided the disease is caused by a defect in the ALK gene.

    Form: capsules, hard

    Active substance Dosage
    ceritinib 150 mg

    ATC: L01E L01ED L01ED02

    Manufacturer: Novartis Europharm Limited